AsOf

Regeneron Pharmaceuticals · quarterly research and development138,862,000 United States dollar

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.

What the statuses mean

Superseded: a later claim replaced it. It was the record's answer for the dates it held.

Valid from
2012-03-31
Valid until
2012-06-30
Published
2012-04-26
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95
Replaced by
147,373,000 United States dollar

Sources

Cite this claim

Each form names the value, its as-of date (2012-03-31), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Regeneron Pharmaceuticals quarterly research and development: 138,862,000 United States dollar", as of 2012-03-31 (until 2012-06-30). Claim clm_F56438C2065F, https://asof.is/claim/clm_F56438C2065F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm.
APA
AsOf. (2012). Regeneron Pharmaceuticals quarterly research and development: 138,862,000 United States dollar (as of 2012-03-31 (until 2012-06-30)) [Record clm_F56438C2065F]. Retrieved November 9, 2026, from https://asof.is/claim/clm_F56438C2065F (source: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm)
BibTeX
@misc{asof_clm_F56438C2065F,
  author = {AsOf},
  title = {Regeneron Pharmaceuticals quarterly research and development: 138,862,000 United States dollar},
  year = {2012},
  howpublished = {\url{https://asof.is/claim/clm_F56438C2065F}},
  note = {Claim clm\_F56438C2065F, as of 2012-03-31 (until 2012-06-30); source: https://www.sec.gov/Archives/edgar/data/872589/000120677412001689/0001206774-12-001689-index.htm},
  urldate = {2026-11-09}
}

Supersedes

On the record

/claim/clm_F56438C2065F.md/v1/claims/clm_F56438C2065Fsubmit a correction